|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.08 USD | +2.34% |
|
-3.74% | +30.14% |
| Market Cap | 119.19Cr 104.88Cr 97Cr 89Cr 167.97Cr 12TCr 170.79Cr 1.16TCr 452.05Cr 5.64TCr 447.43Cr 437.79Cr 20TCr | P/E 2026 * |
-7.72x | P/E 2027 * | -7.79x |
|---|---|---|---|---|---|
| Enterprise Value | 94Cr 83Cr 77Cr 70Cr 132.24Cr 9.06TCr 134.46Cr 911.37Cr 355.9Cr 4.44TCr 352.27Cr 344.67Cr 15TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
99.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Jade Biosciences, Inc.
| 1 day | +2.34% | ||
| 1 week | -3.74% | ||
| Current month | -9.63% | ||
| 1 month | -8.31% | ||
| 3 months | -19.62% | ||
| 6 months | +23.15% | ||
| Current year | +30.14% |
| 1 week | 19.02 |  | 21.5 |
| 1 month | 19.02 | | 23.36 |
| Current year | 12.45 | | 28 |
| 1 year | 6.67 | | 28 |
| 3 years | 6.56 | | 28 |
| 5 years | 6.56 | | 28 |
| 10 years | 6.56 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tom Frohlich
CEO | Chief Executive Officer | 50 | 28/04/2025 |
Bradford Dahms
DFI | Director of Finance/CFO | 38 | 14/07/2025 |
Sandy Lewis
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tom Frohlich
BRD | Director/Board Member | 50 | 28/04/2025 |
Christopher Cain
BRD | Director/Board Member | 42 | 28/04/2025 |
Eric Dobmeier
CHM | Chairman | 57 | 28/04/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/06/26 | Free | Director | 47,675 | 0.0966% | ||
| 09/06/26 | Free | Director | 34,843 | 0.0706% | ||
| 09/06/26 | Free | Chairman | 34,843 | 0.0706% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.34% | -3.74% | +141.06% | - | 119.19Cr | |
| +1.07% | -3.49% | -3.25% | +12.87% | 4.69TCr | |
| +0.25% | +1.65% | +408.41% | +629.49% | 4.02TCr | |
| -0.27% | +4.45% | +9.93% | +66.92% | 3.62TCr | |
| +0.35% | +0.87% | +3.60% | -8.81% | 3.47TCr | |
| +3.14% | +1.02% | +3.37% | +38.15% | 2.79TCr | |
| -0.73% | +11.84% | +31.97% | +143.53% | 1.68TCr | |
| +0.47% | -2.74% | - | - | 1.67TCr | |
| +0.42% | -5.52% | -3.43% | +9.03% | 1.31TCr | |
| -2.68% | -2.49% | -15.00% | -31.68% | 1.27TCr | |
| Average | +0.44% | +0.37% | +64.07% | +107.44% | 2.46TCr | |
| Weighted average by Cap. | +0.49% | +0.89% | +75.42% | +136.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -17Cr -15Cr -14Cr -13Cr -24Cr -1.67TCr -25Cr -168.21Cr -66Cr -819.77Cr -65Cr -64Cr -2.84TCr | -19Cr -17Cr -16Cr -14Cr -27Cr -1.85TCr -27Cr -185.66Cr -73Cr -904.84Cr -72Cr -70Cr -3.13TCr |
| Net Debt | -25Cr -22Cr -21Cr -19Cr -36Cr -2.45TCr -36Cr -246.21Cr -96Cr -1.2TCr -95Cr -93Cr -4.15TCr | -30Cr -26Cr -25Cr -23Cr -42Cr -2.9TCr -43Cr -291.61Cr -113.88Cr -1.42TCr -112.72Cr -110.29Cr -4.92TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | $20.08 | +2.34% | 6,84,671 |
| 23/26/23 | $19.62 | -1.16% | 3,85,490 |
| 22/26/22 | $19.85 | -3.31% | 7,82,830 |
| 21/26/21 | $20.53 | +4.37% | 9,10,234 |
| 20/26/20 | $19.67 | -5.70% | 6,26,415 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JBIO Stock
Select your edition
All financial news and data tailored to specific country editions
